HK2 and hepatocellular carcinoma: Rapamycin treatment, interference of STAT3 or inhibition of HK2, alone or in combination, has been indicated to be able to suppress the growth of HCC cells [23, 32, 36–40] and the invasion and metastasis behavior of HCC cells [30].